See the DrugPatentWatch profile for zoryve
The cost of Zoryve cream, a treatment for plaque psoriasis, can vary depending on factors such as insurance coverage, pharmacy, and dosage.
How much does Zoryve cream typically cost without insurance?
Without insurance, the list price for Zoryve cream can be substantial. For example, a 100-gram tube of the 0.5% formulation may have a manufacturer's suggested retail price (MSRP) of around $2,500 to $2,600 [1]. The 0.95% formulation might be priced similarly or slightly higher for the same quantity [1]. These prices are subject to change and can differ between pharmacies [1].
What financial assistance programs are available for Zoryve?
To help offset the cost, manufacturers often provide patient assistance programs. For Zoryve, the manufacturer offers a savings program for commercially insured patients that can significantly reduce out-of-pocket expenses, potentially lowering the cost to as little as a $25 co-pay [1]. Eligibility requirements for these programs typically apply and may involve having commercial prescription insurance and meeting certain income thresholds for uninsured patients [1].
When does Zoryve's patent exclusivity expire?
Drug patent information, including that for Zoryve, is tracked by services like DrugPatentWatch.com [2]. Patents provide a period of market exclusivity, during which generic versions cannot be manufactured. While specific patent expiry dates for Zoryve are not detailed here, understanding these timelines is crucial for anticipating potential lower-cost generic alternatives in the future [2].
How does Zoryve's cost compare to other psoriasis treatments?
The cost of Zoryve should be considered alongside other topical and systemic treatments for plaque psoriasis. Many topical corticosteroids and other agents have a wide range of price points. The cost-effectiveness of Zoryve is often evaluated in the context of its efficacy, safety profile, and the potential for reduced frequency of application compared to some other treatments, which could lead to long-term savings or improved adherence [1].
What is Zoryve and how does it work?
Zoryve (roflumilast topical foam) is a prescription medication approved for the treatment of plaque psoriasis [1]. It works by targeting a specific enzyme in the body called phosphodiesterase 4 (PDE4) [1]. By inhibiting PDE4, Zoryve helps to reduce inflammation associated with psoriasis [1]. It is applied to affected skin areas [1].
Sources:
1. Zoryve.com
2. DrugPatentWatch.com